Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Mil Med ; 189(3-4): e915-e918, 2024 Feb 27.
Artigo em Inglês | MEDLINE | ID: mdl-37776527

RESUMO

Guillain-Barre syndrome (GBS) is an acute monophasic immune-mediated polyradiculoneuropathy characterized by rapidly evolving ascending weakness, mild sensory loss, and hypo- or areflexia, typically progressing to peak symptoms over the course of 4 weeks. The precise mechanism is unclear but is proposed to be an immune-mediated reaction with the generation of antibodies against peripheral nerves triggered by a preceding viral infection. Acute motor and sensory axonal neuropathy (AMSAN) is a rare and severe variant of Guillain-Barre syndrome with limited published literature. Discussion of risk factors for this subtype has not been done in a systematic way. This case report involves a 34-year-old, active duty, West African female, who immigrated to the United States in 2019. She presented with worsening diplopia, bilateral distal upper and lower extremity paresthesias as well as progressively worsening bilateral upper extremity weakness. Her clinical picture was complicated by constitutional symptoms, diffuse lymphadenopathy, no preceding viral illness, and marked clinical deterioration. Ultimately, she was diagnosed with acute motor and sensory axonal neuropathy in the setting of a new diagnosis of systemic lupus erythematosus, a rarely described association emphasizing the importance of a thorough evaluation for underlying causes of acute neurologic pathologies.


Assuntos
Síndrome de Guillain-Barré , Lúpus Eritematoso Sistêmico , Humanos , Feminino , Adulto , Síndrome de Guillain-Barré/complicações , Síndrome de Guillain-Barré/diagnóstico , Lúpus Eritematoso Sistêmico/complicações , Anticorpos , Paresia , Diplopia
2.
Endosc Ultrasound ; 9(6): 392-396, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32687074

RESUMO

BACKGROUND AND OBJECTIVE: EUS-guided-biliary drainage (EUS-BD) is an efficacious and safe option for patients who fail ERCP. EUS-BD is a technically challenging procedure. The aim of this study was to define the learning curve for EUS-BD. METHODS: Consecutive patients undergoing EUS-BD by a single operator were included for a prospective registry over 6 years. Demographics, procedural information, adverse events, and follow-up data were collected. Nonlinear regression and CUSUM analyses were conducted for the learning curve. Technical success was defined as successful stent placement. Clinical success was defined as resolution of jaundice and/or at least a 30% reduction in the pretreatment bilirubin level within a week after placement or normalization of bilirubin within 30 days. RESULTS: Seventy-two patients were included in the study (53% male, mean age 67 years). Technical success was achieved in 69 patients (96%). Clinical success was achieved in 59/69 patients (86%). Seven patients (10%) had adverse events including bleeding (n = 6) and liver abscess (n = 1). The median procedural time was 59 min (range 36-138 min). This was achieved at the 32nd procedure. Procedural durations were further reduced to 50 min and below after the 50th procedure in a nonlinear pattern. This suggests that procedural durations approach a potential plateau after 100 cases. CONCLUSION: Endoscopists experienced in EUS-BD are expected to achieve a reduction in procedural time over successive cases, with efficiency reached at 59 min and a learning rate of 32 cases. Continued improvement is demonstrated with additional experience, with mastery suggested after approximately 100 cases.

4.
Mil Med ; 179(10): 1149-57, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25269134

RESUMO

Recent years have seen the emergence and proliferation of "legal highs" or "designer drugs," compounds purposefully designed as legal alternatives to controlled substances of abuse. This article describes methoxetamine, a dissociative drug belonging to the arylcyclohexylamine class including phencyclidine and ketamine. Methoxetamine acts principally on the glutamatergic N-methyl-D-aspartate receptor and the serotonin receptor. It is sold as a white or off-white powder. Marketed as a "bladder friendly" alternative to ketamine, preliminary research suggests renal and cystic toxicity similar to ketamine. Methoxetamine is primarily ingested nasally, though also orally, intramuscularly, intravenously, and rectally. Users report dissociative features and, at higher doses, an "m-hole" experience akin to ketamine's "k-hole" described as extreme depersonalization and derealization. The 13 cases of acute methoxetamine toxicity described in the literature are summarized. The toxidrome consists of dissociation/delirium, sympathetic activation, and cerebellar symptoms. Methoxetamine is not detected in standard urine drug tests and there are no reliable laboratory findings. Management of acute methoxetamine toxicity is supportive, consisting of benzodiazepines, antiemetics, intravenous fluids, and respiratory support as indicated. Should methoxetamine conform to the observed 2-year lag of designer drugs migrating from Europe to the United States usage may increase in early 2014.


Assuntos
Cicloexanonas/toxicidade , Cicloexilaminas/toxicidade , Drogas Desenhadas/toxicidade , Drogas Ilícitas/toxicidade , Militares , Humanos , Transtornos Relacionados ao Uso de Substâncias/diagnóstico , Transtornos Relacionados ao Uso de Substâncias/terapia , Estados Unidos
5.
Mil Med ; 178(11): 1245-9, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24183774

RESUMO

INTRODUCTION: Medical students are interested in maximizing clinical experiences during preclinical years; we report an exploratory survey of student and faculty interest in a student-run health clinic (SHC) at the Uniformed Services University of the Health Sciences (USU). METHODS: We distributed via e-mail a questionnaire to explore student and faculty opinions regarding the role of a SHC at the USU. RESULTS: Nearly half of the students (310/669; 46%) and one in five faculty members (78/427; 18%) responded. 227 students stated the USU should have a SHC and 247 students were willing to commit time to a SHC on a weekly or monthly basis. The majority of participants believe work in a SHC would benefit various clinical attributes representative of the Accreditation Council for Graduate Medical Education residency accreditation requirements. However, most participants believe work in a SHC would benefit only students pursuing careers in primary care whereas having less benefit to surgical careers. CONCLUSION: Our survey suggests that there is sufficient student interest at the USU to explore additional clinical opportunities early in the medical school experience; we furthermore identified a subtle yet profound difference of opinions in students and faculty regarding the benefits of early clinical exposure and different specialties.


Assuntos
Atitude do Pessoal de Saúde , Escolha da Profissão , Educação de Graduação em Medicina/métodos , Docentes de Medicina/normas , Medicina Militar/educação , Faculdades de Medicina , Estudantes de Medicina/psicologia , Adulto , Coleta de Dados , Feminino , Humanos , Masculino , Percepção , Inquéritos e Questionários , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA